Therefore, silencing SOAT1 may significantly reduce the survival rate of glioma cells under RT by increasing the level of lipid peroxidation, whereas SLC40A1 OE and DFO, increases the survival rate of glioma cells by reducing the level of lipid peroxidation. This evidence concerns the gene SLC40A1 and central nervous system cancer.